SCHEMBL12428259

SCHEMBL12428259

C/C(=C1/C(=O)N(c2ccccc2)N=C1C(=O)O)c1ccc(-c2ccc3c(c2)CCCN3c2ccc(C)cc2)s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.39
ALDH1A1 P00352 5/20 0.35
TSHR P16473 2/20 0.35
MAPT P10636 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GAA P10253 1/20 0.35
CREBBP Q92793 1/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TP53 P04637 1/20 0.34
OPRM1 P35372 3/20 0.34
OPRD1 P41143 3/20 0.34
OPRK1 P41145 3/20 0.34
KCNQ2 O43526 1/20 0.34
ACHE P22303 1/20 0.34
EED O75530 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12428272 0.88 SCN9A (0.36) SCN9AALDH1A1TSHRMAPTMEN1
SCHEMBL12428249 0.84 EP300 (0.41) SCN9AALDH1A1MAPTMEN1KMT2A
SCHEMBL12428264 0.83 EP300 (0.40) SCN9AALDH1A1MAPTMEN1KMT2A
SCHEMBL12428261 0.83 EP300 (0.40) SCN9AALDH1A1MAPTMEN1KMT2A
SCHEMBL12428258 0.82 MAPT (0.36) SCN9AALDH1A1TSHRMAPTMEN1
SCHEMBL12428372 0.81 OPRM1 (0.45) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL12428273 0.79 SCN9A (0.36) SCN9AALDH1A1MAPTMEN1KMT2A
SCHEMBL12428451 0.77 SCN9A (0.38) SCN9AALDH1A1MAPTMEN1KMT2A
SCHEMBL12428430 0.76 SCN9A (0.42) SCN9AALDH1A1MAPTMEN1KMT2A
SCHEMBL12428121 0.75 KAT8 (0.45) ALDH1A1MAPTMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed
EP-1885015-A1 DYE-SENSITIZED PHOTOELECTRIC CONVERSION DEVICE Nippon Kayaku Kabushiki Kaisha (JP) 2008-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 SCN9A 175/4885ALDH1A1 235/4885TSHR 2488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.